Who Is Scott Gottlieb? – Was sworn in as the 23rd Commissioner of Food and Drugs on May
11, 2017. Dr. Gottlieb is a physician, medical policy expert, and public health advocate
who previously served as the FDA’s Deputy Commissioner for Medical and Scientific
Affairs and before that, as a senior advisor to the FDA Commissioner.
He also worked on the implementation of the Medicare drug benefit as a senior advisor to
the Administrator of the Centers for Medicare and Medicaid Services, where he
supported policy work on quality improvement and the agency’s coverage process,
particularly as it related to new medical technologies.
In 2013 Dr. Gottlieb was appointed by the Senate to serve on the Federal Health
Information Technology Policy Committee, which advises the Department of Health and
Human Services on healthcare information technology.
Dr. Gottlieb was previously a Resident Fellow at the American Enterprise Institute, and
a Clinical Assistant Professor at the New York University School of Medicine in
Manhattan, where he also practiced medicine as a hospitalist physician.
He completed a residency in internal medicine at the Mount Sinai Medical Center in
New York, New York and is a graduate of the Mount Sinai School of Medicine and of
Wesleyan University, in Middletown, Connecticut, where he studied Economics.
Former FDA Commissioner Dr. Scott Gotlieb said that he thinks that the COVID-19 vaccine will at some point become a “three-dose vaccine.”
Dr. Scott Gottlieb, former FDA commissioner, and CNBC contributor joins ‘Squawk Box’ to discuss Germany’s soaring Covid-19 infections and the state of the pandemic in the U.S. For access to live and exclusive video from CNBC.
You may also like:
- America is a tinderbox after teenager is cleared of gunning down two BLM protesters
- More than HALF of NYPD cops wish they never joined force, internal memo says
- Former NFL Player Zac Stacy Free on Bail Despite ‘Horrific Video of Blatant Egregious Domestic Violence,’ Victim Says She Fears for Her Safety
